It seems that there is no content provided for summarization. Please provide the text you would like me to summarize.
NVO has been in the news recently: Novo Nordisk has settled a patent lawsuit with Hims & Hers, enabling the telehealth platform to sell its weight-loss drugs Ozempic and Wegovy. Following this agreement, shares of Hims & Hers surged significantly, reflecting the positive impact of the deal on their business.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.